Rezulin (troglitazone) for Type II diabetes

    This month, Parke-Davis will start marketing Rezulin (troglitazone) for Type II diabetes.

    This is the first drug in a new class...called "glitazones." These drugs are very useful...they improve insulin sensitivity.

    Troglitazone stimulates the uptake of glucose into skeletal muscle cells...and decreases glucose production in the liver.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote